5WHZ | pdb_00005whz

PGDM1400-10E8v4 CODV Fab


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 3.55 Å
  • R-Value Free: 
    0.287 (Depositor), 0.302 (DCC) 
  • R-Value Work: 
    0.239 (Depositor), 0.251 (DCC) 
  • R-Value Observed: 
    0.242 (Depositor) 

Starting Models: experimental
View more details

wwPDB Validation 3D Report Full Report

Validation slider image for 5WHZ

This is version 1.3 of the entry. See complete history

Literature

Trispecific broadly neutralizing HIV antibodies mediate potent SHIV protection in macaques.

Xu, L.Pegu, A.Rao, E.Doria-Rose, N.Beninga, J.McKee, K.Lord, D.M.Wei, R.R.Deng, G.Louder, M.Schmidt, S.D.Mankoff, Z.Wu, L.Asokan, M.Beil, C.Lange, C.Leuschner, W.D.Kruip, J.Sendak, R.Do Kwon, Y.Zhou, T.Chen, X.Bailer, R.T.Wang, K.Choe, M.Tartaglia, L.J.Barouch, D.H.O'Dell, S.Todd, J.P.Burton, D.R.Roederer, M.Connors, M.Koup, R.A.Kwong, P.D.Yang, Z.Y.Mascola, J.R.Nabel, G.J.

(2017) Science 358: 85-90

  • DOI: https://doi.org/10.1126/science.aan8630
  • Primary Citation Related Structures: 
    5WHZ

  • PubMed Abstract: 

    The development of an effective AIDS vaccine has been challenging because of viral genetic diversity and the difficulty of generating broadly neutralizing antibodies (bnAbs). We engineered trispecific antibodies (Abs) that allow a single molecule to interact with three independent HIV-1 envelope determinants: the CD4 binding site, the membrane-proximal external region (MPER), and the V1V2 glycan site. Trispecific Abs exhibited higher potency and breadth than any previously described single bnAb, showed pharmacokinetics similar to those of human bnAbs, and conferred complete immunity against a mixture of simian-human immunodeficiency viruses (SHIVs) in nonhuman primates, in contrast to single bnAbs. Trispecific Abs thus constitute a platform to engage multiple therapeutic targets through a single protein, and they may be applicable for treatment of diverse diseases, including infections, cancer, and autoimmunity.


  • Organizational Affiliation
    • Sanofi, 640 Memorial Drive, Cambridge, MA 02139, USA.

Macromolecule Content 

  • Total Structure Weight: 80.4 kDa 
  • Atom Count: 5,169 
  • Modeled Residue Count: 677 
  • Deposited Residue Count: 734 
  • Unique protein chains: 2

Macromolecules

Find similar proteins by:|  3D Structure
Entity ID: 1
MoleculeChains  Sequence LengthOrganismDetailsImage
Anti-HIV CODV-Fab Light chainA [auth L]338Homo sapiensMutation(s): 0 
Find similar proteins by:|  3D Structure
Entity ID: 2
MoleculeChains  Sequence LengthOrganismDetailsImage
Anti-HIV CODV-Fab Heavy chainB [auth H]396Homo sapiensMutation(s): 0 

Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 3.55 Å
  • R-Value Free:  0.287 (Depositor), 0.302 (DCC) 
  • R-Value Work:  0.239 (Depositor), 0.251 (DCC) 
  • R-Value Observed: 0.242 (Depositor) 
Space Group: P 65 2 2
Unit Cell:
Length ( Å )Angle ( ˚ )
a = 151.226α = 90
b = 151.226β = 90
c = 200.595γ = 120
Software Package:
Software NamePurpose
PHENIXrefinement
PDB_EXTRACTdata extraction
XDSdata reduction
XDSdata scaling
PHASERphasing

Structure Validation

View Full Validation Report



Entry History 

Deposition Data

Revision History  (Full details and data files)

  • Version 1.0: 2017-10-11
    Type: Initial release
  • Version 1.1: 2017-10-18
    Changes: Database references
  • Version 1.2: 2023-10-04
    Changes: Data collection, Database references, Refinement description
  • Version 1.3: 2024-10-16
    Changes: Structure summary